How the advent of anti-VEGF has completely reshaped management of DME. This month’s feature takes a look at the DRCR.net trials—and an overview of new treatments in the pipeline.
The March supplement from MedEdicus can be found here: Improving Treatment Burden and Outcomes for Patients With Neovascular Age-Related Macular Degeneration Now and Into the Future.
Does your practice have a MIPS point person? Make sure they have access to EyeNet’s MIPS 2020: A Primer and Reference, which is posted online ahead of print.
All content on the Academy’s website is protected by copyright law and the Terms of Service. This content may not be reproduced, copied, or put into any artificial intelligence program, including large language and generative AI models, without permission from the Academy.